Biomarin Pharmaceutical (BMRN) EBT (2009 - 2026)
Biomarin Pharmaceutical (BMRN) recorded EBT of $61.38 million in Q2 2026, down 79.4% from $297.87 million a year earlier and down 56.5% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) EBT (2009 - 2026) Analysis & Trends
On a TTM basis, Biomarin Pharmaceutical's EBT came in at $149.11 million as of Jun 30, 2026, down 82.2% year-over-year; for FY2025, it came in at $482.48 million, down 10.9% from FY2024.
- Across earlier years, EBT came in at $541.76 million in FY2024 (+187.3%), $188.56 million in FY2023 (+26.1%), $149.58 million in FY2022 and -$75.35 million in FY2021.
- Quarterly EBT has ranged from -$66.57 million in Q4 2021 to $297.87 million in Q2 2025 over the past five years.
- On a year-over-year basis, EBT rose in four of the last six quarters, with growth averaging 188.5%.
- Peak year-over-year performance for EBT in the last five years was growth of 777.7% in Q4 2024, against a decline of 79.4% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $141.2 million (Q1 2026), -$27.15 million (Q4 2025) and -$26.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.39 Bn |
| 10 | Biomarin Pharmaceutical | 11.51 Bn | 5.37 Bn | 786.91 Mn | 61.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61.38 Mn |
| Mar 31, 2026 | 141.20 Mn |
| Dec 31, 2025 | -27.15 Mn |
| Sep 30, 2025 | -26.32 Mn |
| Jun 30, 2025 | 297.87 Mn |
| Mar 31, 2025 | 238.09 Mn |
| Dec 31, 2024 | 169.64 Mn |
| Sep 30, 2024 | 134.44 Mn |
| Jun 30, 2024 | 132.14 Mn |
| Mar 31, 2024 | 105.55 Mn |
| Dec 31, 2023 | 19.33 Mn |
| Sep 30, 2023 | 41.67 Mn |
| Jun 30, 2023 | 70.81 Mn |
| Mar 31, 2023 | 56.76 Mn |
| Dec 31, 2022 | -17.56 Mn |
| Sep 30, 2022 | -1.90 Mn |
| Jun 30, 2022 | 34.85 Mn |
| Mar 31, 2022 | 134.19 Mn |
| Dec 31, 2021 | -66.57 Mn |
| Sep 30, 2021 | -46.16 Mn |
API Access
Biomarin Pharmaceutical EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();